Mirum appoints William Fairey to board, replacing Tiba Aynechi

Mirum Pharmaceuticals, Inc.

Tiba Aynechi resigned from the board effective August 19, 2021; no dispute or disagreement cited.
William Fairey appointed to board effective August 19, 2021; will serve as Class I director through 2023 annual meeting.
Fairey granted stock option for 34,000 shares vesting over 3 years; annual cash retainer of $40K plus $10K for Audit Committee.
Fairey brings ~30 years biotech commercial experience; previously at MyoKardia, ChemoCentryx, and Actelion.
Company preparing for first U.S. product launch; board also appointed Carol Brosgart and Patrick Heron to committees.

item 5.02 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Tiba Aynechi

Director

MIRM · Mirum Pharmaceuticals, Inc.

Effective: 2021-08-19
Filed: August 20, 2021, 7:59 PM ET

On August 16, 2021, Tiba Aynechi, Ph.D. notified the board of directors (the “Board”) of Mirum Pharmaceuticals, Inc. (the “Company”) of her resignation as a director of the Company, effective August 19, 2021.

Appointed

William Fairey

Director

MIRM · Mirum Pharmaceuticals, Inc.

Effective: 2021-08-19
Filed: August 20, 2021, 7:59 PM ET

On August 19, 2021, the Board, upon recommendation of the Nominating and Corporate Governance Committee of the Board, appointed William Fairey to the Board, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Tiba Aynechi resigned as Director at Mirum Pharmaceuticals, Inc..

Action: resigned
Role: Director

Exact text from the filing

On August 16, 2021, Tiba Aynechi, Ph.D. notified the board of directors (the “Board”) of Mirum Pharmaceuticals, Inc. (the “Company”) of her resignation as a director of the Company, effective August 19, 2021.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

William Fairey was appointed as Director at Mirum Pharmaceuticals, Inc..

Action: appointed
Role: Director

Exact text from the filing

On August 19, 2021, the Board, upon recommendation of the Nominating and Corporate Governance Committee of the Board, appointed William Fairey to the Board, effective immediately.

View on SEC.gov

Mirum Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-21-251740

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.